A fetal response to chorioamnionitis is associated with early survival after preterm birth

The purpose of this study was to determine, in a large preterm cohort (20-34 completed weeks of gestation), the incidence of histologic chorioamnionitis and the incidence of a histologic fetal response to chorioamnionitis (umbilical vasculitis with or without funisitis) in neonatal survivors (to 28...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 2004, Vol.190 (1), p.147-151
Hauptverfasser: Lahra, Monica M, Jeffery, Heather E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The purpose of this study was to determine, in a large preterm cohort (20-34 completed weeks of gestation), the incidence of histologic chorioamnionitis and the incidence of a histologic fetal response to chorioamnionitis (umbilical vasculitis with or without funisitis) in neonatal survivors (to 28 days) and perinatal deaths. Placental histopathology was reviewed (n = 3928 reports). In a subset of this cohort (n = 2076 reports), evidence of a histologic fetal response was compared in neonatal survivors and perinatal deaths. The incidence of histologic chorioamnionitis ranged from 66% at 20 to 24 weeks of gestation (n = 261 neonates) to 16% at 34 weeks (n = 770 neonates). The overall incidence was 31% (n = 3928 neonates). At 25 to 29 weeks of gestation, neonatal survivors had a higher incidence of histologic chorioamnionitis ( P = .02; 95% CI, 1.02-1.21). In addition, neonatal survivors had a higher incidence of a histologic fetal response to chorioamnionitis at 25 to 29 weeks of gestation ( P = .01; 95%CI, 0.33-0.86) and 30 to 34 weeks of gestation ( P = .02; 95%CI, 0.18-0.85). Histologic chorioamnionitis is inversely related to gestational age. Both histologic chorioamnionitis and a histologic fetal response to chorioamnionitis were observed to be more common in preterm survivors of the neonatal period.
ISSN:0002-9378
1097-6868
DOI:10.1016/j.ajog.2003.07.012